Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps his Department is taking to improve outcomes for blood cancer patients in the context of the covid-19 induced (a) diagnosis and (b) treatment backlogs.

To support the recovery of elective services, we are allocating more than £8 billion from 2022/23 to 2024/25, in addition to the £2 billion Elective Recovery Fund and £700 million Targeted Investment Fund made available to systems in 2021/22 to increase elective activity. We will address outcomes for patients, including those with blood cancer, through the delivery of nine million additional treatments and diagnostic procedures over the next three years and approximately 30% more elective activity by 2024/25 than pre-pandemic levels.